NCT02983084 is a NA clinical trial of Orthodontic archwire in Malocclusion, sponsored by Ormco Corporation.

Who is sponsoring NCT02983084?

NCT02983084 is sponsored by Ormco Corporation.

What drugs are being tested in NCT02983084?

Interventions in NCT02983084: Orthodontic archwire.

What condition does NCT02983084 study?

NCT02983084 studies Malocclusion.

Is NCT02983084 still recruiting?

NCT02983084 is currently status unknown. Last updated 15 January 2019.

Last reviewed 2019-01-15 · How we verify

NCT02983084

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Orthodontic Archwire Comparison Trial

Status unknown NA Last updated 15 January 2019

What this trial tests

NA trial testing Orthodontic archwire in Malocclusion in 105 participants. Status unknown.

Timeline

1 December 2016

Primary endpoint
31 December 2019

31 March 2020

Quick facts

Lead sponsor	Ormco Corporation
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	105
Start date	1 December 2016
Primary completion	31 December 2019
Estimated completion	31 March 2020
Sites	1 location across United States

Drugs / interventions tested

Orthodontic archwire

Conditions studied

Malocclusion — all drugs for Malocclusion →

Sponsor

Ormco Corporation

Who can join

18 and older, any sex, with Malocclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized clinical trial (RCT) is to compare traditional CuNiTi archwires and a recently marketed multiforce version of the same material for the initial alignment and leveling of dental arches, as well as the expression of EARR in adult orthodontic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Malocclusion

Currently open trials in the same condition.

NCT05684510 — Treatment of Mild Class II Malocclusion in Adult Patients With Clear Aligners Versus Fixed Multibracket Therapy · NA · recruiting
NCT07290790 — A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSm · NA · recruiting
NCT06858670 — Effectiveness of Auxiliary Segmental Lingual Appliances in Leveling the Curve of Wilson at Second Molars · NA · recruiting
NCT06536335 — Evaluation of the Perceived Experience of Patients Treated With Aligners With Two Different Timings · NA · recruiting
NCT07094581 — Evaluation of the Effect of Adenoid Hypertrophy on the Masseter Muscle in Children: A Comparative Ultrasonographic Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02983084 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ormco Corporation
Last refreshed: 15 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02983084.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing